News Pfizer to end $160bn Allergan merger after US tax changes US Treasury move means mega-merger no longer feasible
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
